文献速递胃肠外科

胃癌手术教科书结局与长期生存:安大略省PRESTO登记分析

Textbook Outcome and Survival in Patients With Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO).
PubMed 文献 · Ann Surg · 2022-01-01

基于安大略省PRESTO登记2004–2015年1836例非转移性胃腺癌胃切除术患者,22%达到教科书结局(TO)。TO患者3年生存率75%对55%(P<0.001),校正后TO与死亡风险降低41%相关(aHR 0.59,95%CI 0.48–0.72,P<0.001)。

要点

  • 胃癌胃切除术中仅22%患者达到全部TO指标。
  • 达到TO者3年生存率75%,未达到者为55%。
  • TO与死亡风险降低41%独立相关(aHR 0.59)。

核心结论

  • 达到教科书结局与胃癌患者长期生存改善强烈相关,值得在外科质量改进中重点关注。

研究设计与样本

  • 基于安大略省PRESTO人群登记2004–2015年所有非转移性胃腺癌胃切除术患者,共1836例。
  • TO定义为切缘阴性、淋巴结采样>15枚、无严重并发症、无再干预、无计划外ICU入住、住院≤21天、无30天再入院及无30天死亡。
  • 采用Kaplan-Meier法估计3年生存,边际多变量Cox比例风险模型评估TO与长期生存关联,E值法评估残余混杂风险。

主要发现

  • 1836例中402例(22%)达到全部TO指标。
  • TO患者3年生存率75%,非TO患者55%(log-rank P<0.001)。
  • 校正协变量及医院内聚类后,TO与死亡风险降低41%相关(aHR 0.59,95%CI 0.48–0.72,P<0.001)。
  • 结果对潜在残余混杂稳健。

关键数值与推荐

  • TO指标:切缘阴性;淋巴结采样>15枚;无严重并发症;无再干预;无计划外ICU入住;住院≤21天;无30天再入院;无30天死亡。

临床怎么用

  • 可将TO作为胃癌手术质量改进的复合评价指标,关注切缘、淋巴结清扫、并发症及住院资源使用等环节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the association between Textbook Outcome (TO)-a new composite quality measurement-and long-term survival in gastric cancer surgery. BACKGROUND: Single-quality indicators do not sufficiently reflect the complex and multifaceted nature of perioperative care in patients with gastric adenocarcinoma. METHODS: All patients undergoing gastrectomy for nonmetastatic gastric adenocarcinoma registered in the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO) between 2004 and 2015 were included. TO was defined according to negative margins; >15 lymph nodes sampled; no severe complications; no re-interventions; no unplanned ICU admission; length of stay ≤21 days; no 30-day readmission; and no 30-day mortality. Three-year survival was estimated using the Kaplan-Meier method. A marginal multivariable Cox proportional-hazards model was used to estimate the association between achieving TO metrics and long-term survival. E-value methodology was used to assess for risk of residual confounding. RESULTS: Of the 1836 patients included in this study, 402 (22%) achieved all TO metrics. TO patients had a higher 3-year survival rate compared to non-TO patients (75% vs 55%, log-rank P < 0.001). After adjustments for covariates and clustering within hospitals, TO was associated with a 41% reduction in mortality (adjusted hazards ratio 0.59, 95% confidence interval 0.48, 0.72, P < 0.001). These results were robust to potential residual confounding. CONCLUSIONS: Achieving TO is strongly associated with improved long-term survival in gastric cancer patients and merits further focus in surgical quality improvement efforts.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Levy J, Gupta V, Amirazodi E, et al. Textbook Outcome and Survival in Patients With Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO). Ann Surg. 2022. PMID: 32149825. doi:10.1097/SLA.0000000000003849

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。